FHTX
Foghorn Therapeutics Inc
2.00$
+0.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +40.2% | +13.9% | -2.4% | -85.3% | +1,639.0% | +449.8% | +14.5% | +47.8% | -36.9% | +26.9% | +5.5% | +212.2% | -67.0% | -12.5% | +36.4% | +13.4% | -63.4% | +108.4% | +27.0% | +7.9% | +13.4% | -64.7% | +391.9% | – | |
| – | – | – | – | – | – | – | +19.7% | -14.9% | +18.5% | +18.2% | -96.5% | +3,226.1% | -0.4% | +9.9% | +9.6% | +9.1% | +6.0% | +3.7% | +4.8% | -92.7% | +1,320.5% | -10.2% | -96.8% | -2.0% | -4.2% | -12.5% | +8.7% | – | – | +2,122.4% | -96.0% | -70.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -274.3% | – | – | – | – | – | – | – | – | – | -545.5% | – | – | +2.7% | +36.4% | +13.4% | -63.4% | +108.4% | +11.8% | -278.0% | – | -64.1% | +430.6% | – | |
| – | +0.0% | +0.0% | +109.0% | -11.9% | +0.0% | +15.5% | +19.7% | -14.9% | +18.5% | +18.2% | -1.3% | +17.7% | -0.4% | +9.9% | +9.6% | +9.1% | +6.0% | +3.7% | +4.8% | +6.3% | -2.5% | -10.2% | -11.0% | +9.3% | -6.8% | +3.7% | -16.9% | +5.5% | -3.4% | -4.3% | +14.7% | -20.4% | +1.4% | – | |
| – | +0.0% | +0.0% | +39.3% | -3.4% | +0.0% | +11.3% | -7.9% | +33.3% | -14.0% | +33.7% | +78.4% | +2.9% | +4.4% | +18.6% | +9.0% | +14.0% | +6.8% | +3.4% | -1.3% | +9.9% | -2.8% | -1.1% | -15.5% | +9.8% | -5.0% | -4.8% | -8.9% | +13.9% | -5.2% | -3.1% | +2.2% | -3.2% | -3.4% | – | |
| – | – | – | – | – | +0.0% | +14.9% | +15.9% | -9.6% | +13.2% | +20.1% | +9.6% | -77.1% | +4.4% | +18.6% | +9.0% | +14.0% | +6.8% | +3.4% | -1.3% | +391.3% | -78.3% | -1.1% | +265.6% | +9.4% | +0.8% | -5.5% | -15.2% | +7.5% | -3.8% | -76.0% | +321.5% | -12.3% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +45.6% | +0.0% | +0.0% | -16.3% | +57.5% | +44.9% | -23.3% | +2.0% | +58.9% | +51.4% | +1.9% | +0.8% | -14.6% | +108.9% | +110.7% | +32.8% | +111.0% | -56.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | -40.5% | +258.3% | -94.6% | +130,963.6% | +11.8% | -96.9% | +2.4% | +5.4% | -14,611.1% | – | – | -232.8% | – | -89.3% | +68.2% | -21.7% | +169.1% | -60.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.